Global Chenodeoxycholic Acid Market Growth 2025-2031

The global Chenodeoxycholic Acid market size is predicted to grow from US$ 405 million in 2025 to US$ 582 million in 2031; it is expected to grow at a CAGR of 6.2% from 2025 to 2031.

Chenodeoxycholic acid (also known as chenodesoxycholic acid, chenocholic acid and 3α,7α-dihydroxy-5β-cholan-24-oic acid) is a bile acid. It occurs as a white crystalline substance insoluble in water but soluble in alcohol and acetic acid, with melting point at 165–167 °C. Salts of this carboxylic acid are called chenodeoxycholates. Chenodeoxycholic acid is one of the main bile acids produced by the liver.

According to the type, Chenodeoxycholic Acid can be divided into 80-90% purity and 95-98% purity. In 2019, the sales of 80-90% purity accounted for more than 97%.

In 2019, the global Chenodeoxycholic Acid market is led by China. Europe is the second-largest region-wise market.

LP Information, Inc. (LPI) ' newest research report, the “Chenodeoxycholic Acid Industry Forecast” looks at past sales and reviews total world Chenodeoxycholic Acid sales in 2024, providing a comprehensive analysis by region and market sector of projected Chenodeoxycholic Acid sales for 2025 through 2031. With Chenodeoxycholic Acid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chenodeoxycholic Acid industry.

This Insight Report provides a comprehensive analysis of the global Chenodeoxycholic Acid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chenodeoxycholic Acid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chenodeoxycholic Acid market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chenodeoxycholic Acid and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chenodeoxycholic Acid.

This report presents a comprehensive overview, market shares, and growth opportunities of Chenodeoxycholic Acid market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
80-90% Purity
95-98% Purity

Segmentation by Application:
Ursodeoxycholic Acid Synthesis
Steroids and Steroid Derivatives

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ICE Group
Zhongshan Belling Biotechnology
PharmaZell GmbH
Suzhou Tianlu Bio-pharmaceutical
Daewoong
Linyi Tianli Biochemical
Changde Yungang Biotechnology
Guanghan Yikang Biological
Tianjin NWS Biotechnology and Medicine
Shandong Zhongjing Biological

Key Questions Addressed in this Report

What is the 10-year outlook for the global Chenodeoxycholic Acid market?

What factors are driving Chenodeoxycholic Acid market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Chenodeoxycholic Acid market opportunities vary by end market size?

How does Chenodeoxycholic Acid break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more